A prospective study of pregravid oral contraceptive use and risk of hypertensive disorders of pregnancy

Contraception

Volumn 60, Issue 3, 1999, Pages 145-150

  Thadhani, Ravi ^a,b   Stampfer, Meir J ^a,c   Chasan Taber, Lisa ^a,d   Willett, Walter C ^a,c   Curhan, Gary C ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Gestational hypertension; Oral contraceptives; Preeclampsia; Prospective cohort study

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HAZARD; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PREECLAMPSIA; QUESTIONNAIRE; RISK ASSESSMENT; SMOKING; STATISTICS;

EID: 0032804645     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(99)00079-7     Document Type: Article

References (36)

1. Kaunitz A.M., Hughes J., Grimes D.A., Smith J.C., Rochat R.W., Kafrissen M.E. Causes of maternal mortality in the United States. Obstet Gynecol. 65:1985;605-612.
2. Zhang J., Zeisler J., Hatch M.C., Berkowitz G. Epidemiology of pregnancy-induced hypertension. Epidemiol Rev. 19:1997;218-232.
3. Sibai B.M. Treatment of hypertension in pregnant women. N Engl J Med. 335:1996;257-265.
4. Levine R.J., Hauth J.C., Curet L.B., et al. Trial of calcium to prevent preeclampsia. N Engl J Med. 337:1997;69-76.
5. CLASP a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women . Lancet. 343:1994;619-629.
6. Chasan-Taber L., Willett W.C., Manson J.E., et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation. 94:1996;483-489.
7. Greenlund K.J., Webber L.S., Srinivasan S., Wattigney W., Johnson C., Berenson G.S. Associations of oral contraceptive use with serum lipids and lipoproteins in young women the Bogalusa Heart Study . Ann Epidemiol. 7:1997;561-567.
8. Godsland I.F., Crook D. Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease. Am J Obstet Gynecol. 170:1994;1528-1536.
9. Sheu W.H., Hsu C., Chen Y., Jeng C., Fuh M.M. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives. Clin Endocrinol. 40:1993;249-255.
10. Lorentzen B., Henriksen T. Plasma lipids and vascular dysfunction in preeclampsia. Semin Reprod Endocrinol. 16:1998;33-39.
11. Kaaja R. Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol. 16:1998;41-46.
12. Thadhani R, Stampfer MJ, Willett WC, et al. High body mass index and hypercholesterolemia; risk of hypertensive disorders of pregnancy. Obstet Gynecol 1999;94:543-50.
13. Joffe G.M., Esterlitz J.R., Levine R.J., et al. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Am J Obstet Gynecol. 179:1998;1032-1037.
14. Lorentzen B., Birkeland K.I., Endersen M.J., Henriksen T. Glucose intolerance in women with preeclampsia. Acta Obstet Gynecol Scand. 77:1998;22-27.
15. Colditz G.A., Martin P., Stampfer M.J., et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 123:1986;894-900.
16. Am J Obstet Gynecol. 163:1990;1689-1712.
17. Sibai B.M., Caritis S.N., Thom E., et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med. 329:1993;1213-1218.
18. Parazzini F., Bortoulus R., Chatenoud L., et al. Risk factors for pregnancy-induced hypertension in women at high risk for the condition. Epidemiology. 7:1996;306-308.
19. Sibai B.M., Gordon T., Thom E., et al. Risk factors for preeclampsia in healthy nulliparous women a prospective multicenter study . Am J Obstet Gynecol. 172:1995;642-648.
20. Meyer N.L., Mercer B.M., Friedman S.A., Sibai B.M. Urinary dipstick protein a poor predictor of absent or severe proteinuria . Am J Obstet Gynecol. 170:1994;137-141.
21. Sibai B.M. Pitfalls in the diagnosis and management of preeclampsia. Am J Obstet Gynecol. 159:1988;1-5.
22. Fisher K.A., Luger A., Spargo B.H., Lindheimer M.D. Hypertension in pregnancy clinical-pathological correlations and remote prognosis . Medicine. 60:1981;267-276.
23. Rothman K.J., Greenland S. Modern Epidemiology. 1998;Little, Brown, Boston.
24. D'Agostino R.B., Lee M.L., Belanger A.J., Cupples L.A., Anderson K., Kannel W.B. Relation of pooled logistic regression to time dependent Cox regression analysis the Framingham Heart Study . Stat Med. 9:1990;1501-1515.
25. Hennekens C.H., Evans D.A., Castell W.P., Taylor J.O., Rosner B., Kass E.H. Oral contraceptive use and fasting triglyceride, plasma cholesterol and HDL cholesterol. Circulation. 60:1979;486-489.
26. Acute myocardial infarction and combined oral contraceptives results of an international multicentre case-control study . Lancet. 349:1997;1202-1209.
27. Braken M.B., Srisuphan W. Oral contraception as a risk factor for preeclampsia. Am J Obstet Gynecol. 142:1982;191-199.
28. Gratacos E., Torres P., Cararach V., Quinto L., Alonso P.L., Fortuny A. Does the use of contraception reduce the risk of pregnancy-induced hypertension? Hum Reprod. 11:1996;2138-2141.
29. Williams J.K., Delansorne R., Paris J. Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys. J Steroid Biochem Mol Biol. 65:1998;219-224.
30. Roberts J.M., Redman C.W. Pre-eclampsia more than pregnancy-induced hypertension . Lancet. 341:1993;1447-1451.
31. O'Brien T., Nguyen T.T. Lipids and lipoproteins in women. Mayo Clin Proc. 72:1997;235-244.
32. Chasan-Taber L., Stampfer M.J. Epidemiology of oral contraceptives and cardiovascular disease. Ann Intern Med. 128:1998;467-477.
33. Klonoff-Cohen H.S., Savitz D.A., Cefalo R.C., McCann M.F. An epidemiologic study of contraception and preeclampsia [see comments]. JAMA. 262:1989;3143-3147.
34. Mills J.L., Klebanoff M.A., Graubard B.I., Carey J.C., Berendes H.W. Barrier contraceptive methods and preeclampsia. JAMA. 265:1991;70-73.
35. Eskenazi B., Fenster L., Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA. 266:1991;237-241.
36. Sibai B.M., Ewell M., Levine R.J., et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) study group. Am J Obstet Gynecol. 177:1997;1003-1010.